Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Alcohol Clin Exp Res ; 38(2): 336-43, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24033682

RESUMO

BACKGROUND: Alcohol abuse increases the risk for acute lung injury (ALI). In both experimental models and in clinical studies, chronic alcohol ingestion causes airway oxidative stress and glutathione depletion and increases the expression of transforming growth factor beta-1 (TGFß1), a potent inducer of fibrosis, in the lung. Therefore, we hypothesized that alcohol ingestion could promote aberrant fibrosis following experimental ALI and that treatment with the glutathione precursor s-adenosylmethionine (SAMe) could mitigate these effects. METHODS: Three-month-old C57BL/6 mice were fed standard chow ± alcohol (20% v/v) in their drinking water for 8 weeks and ±SAMe (4% w/v) during the last 4 weeks. ALI was induced by intratracheal instillation of bleomycin (2.5 units/kg), and lungs were assessed histologically at 7 and 14 days for fibrosis and at 14 days for the expression of extracellular matrix proteins and TGFß1. RESULTS: Alcohol ingestion had no apparent effect on lung inflammation at 7 days, but at 14 days after bleomycin treatment, it increased lung tissue collagen deposition, hydroxyproline content, and the release of activated TGFß1 into the airway. In contrast, SAMe supplementation completely mitigated alcohol-induced priming of these aberrant fibrotic changes through decreased TGFß1 expression in the lung. In parallel, SAMe decreased alcohol-induced TGFß1 and Smad3 mRNA expressions by lung fibroblasts in vitro. CONCLUSIONS: These new experimental findings demonstrate that chronic alcohol ingestion renders the experimental mouse lung susceptible to fibrosis following bleomycin-induced ALI, and that these effects are likely driven by alcohol-mediated oxidative stress and its induction and activation of TGFß1.


Assuntos
Antibióticos Antineoplásicos/toxicidade , Bleomicina/toxicidade , Depressores do Sistema Nervoso Central/toxicidade , Etanol/toxicidade , Fibrose Pulmonar/induzido quimicamente , Actinas/biossíntese , Animais , Antibióticos Antineoplásicos/antagonistas & inibidores , Bleomicina/antagonistas & inibidores , Diferenciação Celular/efeitos dos fármacos , Depressores do Sistema Nervoso Central/antagonistas & inibidores , Dieta , Ensaio de Imunoadsorção Enzimática , Etanol/antagonistas & inibidores , Fibroblastos/efeitos dos fármacos , Fibroblastos/patologia , Hidroxiprolina/metabolismo , Pulmão/patologia , Camundongos , Camundongos Endogâmicos C57BL , Miofibroblastos/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Pneumonia/patologia , Fibrose Pulmonar/patologia , Fibrose Pulmonar/prevenção & controle , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , S-Adenosilmetionina/farmacologia , Fator de Crescimento Transformador beta1/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA